A hydrogen-deuterium exchange mass spectrometry (HDX-MS)-guided structural modeling workflow for efficient and accurate epitope and paratope mapping across three prospective case studies in therapeutic protein discovery and engineering is presented.
Abstract
ABSTRACT Accurate mapping of paratopes and epitopes at antibody-antigen (Ab-Ag) interfaces is essential for the rational design of therapeutic antibodies in early drug development. Traditional methods for determining high-resolution Ab-Ag complex structures, such as X-ray crystallography and cryo-electron microscopy, are labor-intensive and require substantial time and resources. Although recent computational approaches have increased throughput, prediction accuracy and reliability remain limited, particularly without experimental structural constraints. Here, we present a hydrogen-deuterium exchange mass spectrometry (HDX-MS)-guided structural modeling workflow for efficient and accurate epitope and paratope mapping across three prospective case studies in therapeutic protein discovery and engineering. Across these systems, peptide-level HDX-MS data were sufficient to guide docking and structural modeling, whereas targeted electron transfer dissociation (ETD) HDX-MS was applied in one system as a higher-resolution, orthogonal approach to further localize critical binding residues. The workflow was applied to diverse Ab-Ag architectures spanning Fab and VHH binders and homodimeric and heterodimeric antigen ectodomains, and HDX-MS data were integrated with HADDOCK, AlphaFold2, and Protenix to generate Ab-Ag complex models. Comparison with subsequently obtained in-house X-ray crystal structures, used here as orthogonal high-resolution reference structures, showed strong agreement in overall binding orientation and interface placement. These results demonstrate the robustness and practical utility of this integrative approach for structure-informed antibody engineering in therapeutic protein discovery.
Abstract Motivation Antibody–antigen (Ab–Ag) interactions are central to immune recognition and widely exploited in therapeutic design, making accurate structural characterization of these complexes a central challenge in the field. While docking and artificial intelligence–based approaches can generate multiple candid...
Júlia S. Souza, Aline O. Albuquerque, Diego Almeida et al.· Bioinformatics· 0 citations
Accurately modeling biomolecular interactions is crucial for understanding biological function and can accelerate drug discovery efforts. Deep-learning-based cofolding methods such as AlphaFold3 and Boltz-2 can successfully predict many different biomolecular complexes. However, these models show lower success rates in...
Stephanie M. Linker, Tobias Ploetz, Andreas Evers et al.· ChemMedChem· 0 citations
Single-particle cryo-electron microscopy (cryo-EM) plays an increasingly important role in structure-based drug discovery (SBDD) by revealing target protein-ligand interactions at the molecular level, but its application has largely focused on large- and medium-sized protein complexes. Many therapeutically important ta...
Xiao-Run Li, S. Deng, Wei-Hua Li et al.· bioRxiv· 0 citations
Complementarity Determining Regions (CDRs) in antibodies, and in particular the CDR-H3 loop, often display conformational plasticity that is essential for their function. Due to this flexibility, the structural investigation of antibody-antigen binding cannot exclusively rely on experimental techniques that only provid...
Amélie Barozet, M. Mathieu, David Papin et al.· Journal of Structural Biolog...· 0 citations
Small-molecule modulators may complement antibody therapy, offering potential advantages such as optimizable chemical structures, improved tumor accessibility, and better flexibility in pharmacokinetic control. Lymphocyte activation gene-3 (LAG-3) is an inhibitory immune checkpoint receptor that suppresses T-cell funct...
Ke-Jia Ren, Peng-Shan Li, Jia-Cheng Liu et al.· Bioorganic chemistry (Print)· 0 citations
Monoclonal antibody (mAb) therapeutics exhibit substantial structural heterogeneity, requiring analytical methods capable of rapidly assessing critical quality attributes (CQAs) that influence stability and developability. Non-native aggregation is a key CQA, given its propensity to decrease mAb efficacy and increase...
Addison E. Bergman, Michael R. Armbruster, Devin M. Makey et al.· Analytical Chemistry· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.